These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9825789)

  • 1. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales.
    Crampin AC; Lamagni TL; Hope VD; Newham JA; Lewis KM; Parry JV; Gill ON
    Epidemiol Infect; 1998 Oct; 121(2):381-6. PubMed ID: 9825789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.
    Day CA; Topp L; Iversen J; Maher L;
    Drug Alcohol Rev; 2008 Sep; 27(5):559-61. PubMed ID: 18608447
    [No Abstract]   [Full Text] [Related]  

  • 5. Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia.
    Aitken C; Delalande C; Stanton K
    Drug Alcohol Depend; 2002 Feb; 65(3):303-8. PubMed ID: 11841901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales.
    Craine N; Walker AM; Williamson S; Brown A; Hope VD
    Commun Dis Public Health; 2004 Sep; 7(3):216-9. PubMed ID: 15481216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
    Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?
    Marongiu A; Hope VD; Parry JV; Ncube F
    Sex Transm Infect; 2012 Oct; 88(6):456-61. PubMed ID: 22628667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
    Rowe R; Berger I; Yaseen B; Copeland J
    Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
    Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F
    Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection in injecting drug users attending centres in England and Wales, 1990-1991.
    Noone A; Durante AJ; Brady AR; Majid F; Swan AV; Parry JV; Hart GJ; Connell JA; Perry KR; Joce RE
    AIDS; 1993 Nov; 7(11):1501-7. PubMed ID: 8280418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.